Global ADC Market to Reach US$ 3 Billion by 2018
According to a new research report by RNCOS entitled, “Global Antibody Drug Conjugate Market Outlook 2018”, the global market for ADCs is estimated to reach approximately US$ 3 Billion by 2018, growing at a CAGR of around 55% over 2014-2018. The market presently consists of only two ADCs namely, ADCETRIS and Kadcyla. However, these ADCs are also being incorporated with different therapies in various phases of clinical trials, an indication that the coming years will witness stupendous growth.
View full press release